SpyGlass Pharma Files $100M IPO - Orange County Business Journal

SpyGlass Pharma Files for $100 Million IPO

SpyGlass Pharma filed on Friday with the U.S. Securities and Exchange Commission (SEC) to raise up to $100 million in an initial public offering. Founded in 2019, the Aliso Viejo, California–based company is developing durable drug delivery solutions aimed at providing long-term disease control and preserving vision in patients with chronic eye conditions. Its lead product candidate is the 'Bimatoprost Drug Pad–IOL System' (BIM-IOL System), whic…

SpyGlass Pharma Files $100M IPO - Orange County Business Journal

Aliso Viejo-based ophthalmology company SpyGlass Pharma Inc. filed for an initial public offering last Friday. The company, which is developing the world’s first IOL-mounted drug delivery platform capable of continuously releasing glaucoma medication to the eyes, plans to trade on the Nasdaq Global Market under the symbol “SGP”. The size of the offering, or proposed stock price, hasn’t been determined yet. A $100 million placeholder value was gi…